跳至主要内容
临床试验/NCT04968457
NCT04968457进行中(未招募)不适用

Multicenter Post-marketing Survey of SEBBIN Group Silicone Gel-filled Breast Implants

Groupe SEBBIN0 个研究点目标入组 908 人开始时间: 2014年1月最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Groupe SEBBIN
入组人数
908
主要终点
Complication

研究概览

简要总结

The aim of the study is to allow Groupe SEBBIN to communicate to competent authorities and to the scientific community data relative to the safety and effectiveness of SEBBIN silicone gel-filled breast implants.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • The patient is at least 18-year-old.
  • The patient is genetically a woman.
  • The patient is candidate to a breast augmentation or breast reconstruction with silicone gel-filled breast implants.
  • The patient gets all information regarding the study and signs the informed consent relative to the use of her personal data.

排除标准

  • The patient is pregnant or breastfeeding.
  • The patient has silicone implants somewhere else than in the breast.
  • The patient was diagnosed with one of the following pathologies:
  • Systemic lupus erythematous, Sjogren syndrome, scleroderma, polymyositis, or any other connective tissue disease.
  • Rheumatoid arthritis, crystalline arthritis, infectious arthritis, spondyloarthropathies, or any other inflammatory arthritic disease.
  • Arthritis, fibromyalgia, chronic fatigue syndrome, or any other mechanic or degenerative non-inflammatory rheumatic disease.
  • The patient has a pathology that could delay healing (does not apply to the reconstruction group).
  • The patient has cancer (does not apply to the reconstruction group).
  • The patient has anatomical or physiological conditions that could lead to postoperative complications.

结局指标

主要结局

Complication

时间窗: At 10 years of follow-up

complication rate

次要结局

未报告次要终点

研究者

发起方
Groupe SEBBIN
申办方类型
Industry
责任方
Sponsor

相似试验